Abstract
In our previous study, we found that glucocorticoid receptor (GR) gene genetic polymorphisms may play a major role in the efficacy of glucocorticoids (GCs) in Chinese systemic lupus erythematosus (SLE) patients. The aim of this study is to explore the association of GR gene genetic polymorphisms and improvement of health-related quality of life (HRQOL) in Chinese SLE patients treated with GCs. A total of 195 Chinese SLE patients were treated with GCs for 12 weeks. The HRQOL of patients was measured with the Medical Outcomes Study Short Form-36 (SF-36) at baseline and 12 weeks. Polymorphisms of GR gene were genotyped by using multiplex SNaPshot method. One hundred eighty-four patients (94.36 %) completed the 12-week follow-up. Twenty-three single-nucleotide polymorphisms of GR gene were genotyped. There was a significant association between rs10482672 polymorphism and improvement in physical function (P = 0.043), general health (P = 0.024), and social function (P = 0.013). The rs12656106 polymorphism was associated with improvement in the total score of SF-36 (P = 0.014), physical function (P = 0.013), general health (P = 0.010), vitality (P = 0.015), social function (P = 0.004), physical component summary (P = 0.016), and mental component summary (P = 0.014). The rs4912905 polymorphism was associated with improvement in bodily pain (P = 0.040) and general health (P = 0.038). The rs4912911 polymorphism was associated with improvement in general health (P = 0.026) and vitality (P = 0.027). The rs4986593 polymorphism was associated with improvement in bodily pain (P = 0.034). The rs7719514 polymorphism was associated with improvement in vitality (P = 0.002) and mental component summary (P = 0.041). We also found a significant association between rs9324924 polymorphism and improvement in physical function (P = 0.040), bodily pain (P = 0.007), and general health (P = 0.019). These results indicate that there may be an association of GR gene rs10482672, rs12656106, rs4912905, rs4912911, rs4986593, rs7719514, and rs9324924 polymorphisms with improvement of HRQOL in Chinese SLE patients treated with GCs.
Similar content being viewed by others
References
D’Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369:587–596
van Rossum EF, van den Akker EL (2011) Glucocorticoid resistance. Endocr Dev 20:127–136
Zou YF, Xu JH, Wang F et al (2013) Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: a prospective cohort study. Autoimmunity 46:531–536
Zou YF, Xu JH, Tao JH et al (2013) Impact of environmental factors on efficacy of glucocorticoids in chinese population with systemic lupus erythematosus. Inflammation 36:1424–1430
Adcock IM, Nasuhara Y, Stevens DA et al (1999) Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol 127:1003–1011
Francke U, Foellmer BE (1989) The glucocorticoid receptor gene is in 5q31-q32 [corrected]. Genomics 4:610–612
Encío IJ, Detera-Wadleigh SD (1991) The genomic structure of the human glucocorticoid receptor. J Biol Chem 266:7182–7188
WHOQOL Group (1993) Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res 2:153–159
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
Newnham EA, Harwood KE, Page AC (2007) Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36. J Affect Disord 98:91–97
Thumboo J, Strand V (2007) Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singap 36:115–122
Galon J, Franchimont D, Hiroi N et al (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61–71
Mosca M, Tani C, Carli L et al (2011) Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol 29:S126–S129
Nicolaides NC, Galata Z, Kino T et al (2010) The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75:1–12
Manenschijn L, van den Akker EL, Lamberts SW et al (2009) Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann N Y Acad Sci 1179:179–198
Dua AB, Touma Z, Toloza S et al (2013) Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep 15:380
Moldovan I, Katsaros E, Carr FN et al (2011) The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus 20:1285–1292
Anacker C, Zunszain PA, Carvalho LA et al (2011) The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 36:415–425
Gałecka E, Szemraj J, Bieńkiewicz M et al (2013) Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland. Mol Biol Rep 40:1693–1699
Hauer D, Weis F, Papassotiropoulos A et al (2011) Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit Care Med 39:643–650
Rostami S, Parsa-Yekta Z, Najafi-Ghezeljeh T et al (2015) Self-perception in Iranian adolescents with diabetes: a qualitative study. J Diabetes Metab Disord 14:36
Yang J, Lu YW, Pan HF et al (2012) Seasonal distribution of systemic lupus erythematosus activity and its correlation with climate factors. Rheumatol Int 32:2393–2399
Sun S, Chen J, Johannesson M et al (2011) Regional differences in health status in China: population health-related quality of life results from the National Health Services Survey 2008. Health Place 17:671–680
Costedoat-Chalumeau N, Amoura Z, Hulot JS et al (2007) Hydroxychloroquine in systemic lupus erythematosus. Lancet 369:1257–1258
Petri M (2011) Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients. Curr Rheumatol Rep 13:77–80
Carmichael SJ, Charles B, Tett SE (2003) Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Ther Drug Monit 25:671–681
Acknowledgments
We thank all patients for their enthusiastic participation in the study. This work was supported by grants from the National Natural Science Foundation of China (81373073, 81172764, 81102192, 81273169).
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM. 1
(DOC 55 kb)
Rights and permissions
About this article
Cite this article
Zou, YF., Xu, JH., Pan, FM. et al. Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus. Clin Rheumatol 34, 1537–1544 (2015). https://doi.org/10.1007/s10067-015-3027-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-3027-6